Skip to main content
Arthroplasty Today logoLink to Arthroplasty Today
. 2021 Oct 2;12:68–75. doi: 10.1016/j.artd.2021.09.012

Multicenter Evaluation of Telehealth Utilization in Hip and Knee Arthroplasty Before and for One Year During the COVID-19 Pandemic

Stefano Bini a,, Yu-Fen Chiu b, Michael Ast b, Chad Krueger c, Joseph Maratt d, Ilya Bendich b
PMCID: PMC8486641  PMID: 34632025

Abstract

Background

The Coronavirus Disease 2019 (COVID-19) pandemic has led to an increase in telehealth utilization across the health-care sector. It is unknown if telehealth use among hip and knee arthroplasty clinics has remained an important health-care delivery platform. The purpose of the present study was to analyze telehealth utilization before and for 1 year during the pandemic among four varied hip and knee arthroplasty clinics.

Methods

Retrospective data were available from four regionally diverse hip and knee arthroplasty centers. Data on volume of patient visits, demographics, visit types (new visit, follow-up, postoperative visit, other), and visit modality (in-person, telehealth, telephone) were available from January 2020 through April 2021. Data from the centers were analyzed as a total and separately, using chi-squared and Fisher exact tests.

Results

Among the four centers, there were 296,540 hip and knee arthroplasty outpatient clinic visits between January 2020 and April 2021. Of those, 15,240 (5%) were telehealth visits. Before March 2020, less than 0.1% of visits across centers occurred over telehealth. The highest utilization of telehealth visits occurred in March 2020 (>55%) and April 2020 (>25%). From August 2020 until April 2021, telehealth visits accounted for 2%-3% of total visits. Younger patients (<50 years old) were most likely to use telehealth. Follow-up and postoperative were the most likely telehealth visits.

Conclusion

Telehealth utilization peaked during March and April of 2020 and has since reverted to near prepandemic levels. Younger patients and lower complexity visits such as postoperative or follow-up visits are more likely to use telehealth.

Keywords: Primary hip replacement, Primary knee replacement, Telehealth, Healthcare delivery, COVID-19

Introduction

The Coronavirus Disease 2019 (COVID-19) pandemic has impacted the World in innumerable ways. In response to the early COVID-19 pandemic, orthopedic surgery departments across the United States (US) used telehealth services to deliver patient care [1]. The implementation of telehealth was further supported by the Centers for Medicare and Medicaid Services. As of March 2020, the Centers for Medicare and Medicaid Services provided payment parity for telehealth services and allowed for a wide variety of communication platforms to deliver telemedicine, whether they were compliant with the Health Insurance Portability and Accountability Act (HIPPA) or not [2].

Telemedicine and telehealth are often interchangeable terms, both referring to the provision of health-care services from provider to patient in differing locations [3,4]. Before COVID-19 being declared a pandemic by the World Health Organization (WHO) on March 11, 2020 [3], telehealth accounted for less than 1% of all patient visits in the US [4]. After the COVID-19 pandemic, however, 83% of academic orthopedic surgery departments implemented telehealth services [1].

Within orthopedic surgery, total joint arthroplasty providers were early adopters of telehealth [[5], [6], [7]]. Although increased utilization of telehealth was evident in the first several months of the COVID-19 pandemic, it is not known if this represents a lasting or transient care delivery model in arthroplasty [7]. The purpose of this study is to analyze the trends of utilization of telehealth among four varied arthroplasty practices across the US from January 2020 to April 2021. Second, we sought to determine if telehealth is more used among certain patient demographics or specific appointment types.

Material and methods

Data were retrospectively collected from the electronic medical records of four medical centers located in representative areas of the US. Institution review board approval was obtained at each center.

Patients and centers

The patients included in the study were limited to those evaluated in hip and knee arthroplasty clinics among the four included centers. Demographic data were available. The included centers were anonymized and labeled A, B, C, and D. Center A is an academic, specialized orthopedic hospital in the Eastern region of the US. Center B is an academic medical center in the Western region of the US. Center C is a large community-based private clinic in the Midwestern region of the US. Center D is an academic, specialized orthopedic hospital in the Eastern region of the US.

Visit types

Visit types encompassed all outpatient visits to an adult hip and knee reconstruction clinic at one of the four centers. Visits were classified as “new patient visits,” “follow-up visits,” “postoperative visits,” and “other visits.” Visits were also characterized by whether they occurred in-person, over telehealth platforms, or over telephone. These data were reported monthly by each site.

Data compilation and reporting

To provide anonymity to each of the four centers, the total volume of visits in the four centers were reported in absolute values. The data for each center are otherwise reported in percentages rather than absolute values.

Data analysis

Patient visits to each center, subclassified by sex, appointment types, and age groups, were presented as frequencies and percentages and compared using the chi-squared test or the Fisher exact test, as appropriate. The comparisons for utilization difference in the trends over time between centers were conducted using a Cochran-Armitage test for trend. All tests were 2-sided. Significance was defined as P < .05. Statistical analyses and data visualizations were performed using SAS 9.4 (SAS Institute Inc., Cary, NC) and Rstudio 1.2.5042 (RStudio, Inc., Boston, MA).

Results

Overall study period results

A total of 296,540 hip and knee arthroplasty outpatient clinic visits occurred between January 2020 and April 2021 among the four centers included in this study. Of these, a total of 15,240 (5%) were telehealth visits. Centers had a difference in overall telehealth utilization during the study period (Table 1). Fifty-seven percent of all visits and 57% of all telehealth visits were by females. Furthermore, during this time period, the highest utilization category for telehealth was among follow-up visits and in patients younger than 50 years (Table 2; Fig. 1).

Table 1.

Total and center-specific utilization of in-person, telehealth, and telephone visits broken out by sex, appointment type, age group.

Variable Total N = 296,540)
Center A
Center B
Center C
Center D
n % % % % %
Utilization
 In-person 280,559 95 92 84 96 96
 Telehealth 15,240 5 7 14 4 4
 Telephone 741 0 1 2 0 0
Sex
 Female 170,296 57 58 61 57 57
 Male 126,034 43 42 39 43 43
 N/A 210 0 0 0 0 0
Appt
 FollowUp 120,949 41 41 52 1 42
 NewPatient 37,623 13 31 29 18 6
 Other 93,730 32 5 0 55 40
 PostOp 44,236 15 24 19 27 12
Age group
 50 or Less 15,432 5 9 9 19 3
 50 to 70 163,175 55 55 54 51 55
 70 and Above 117,911 40 36 37 30 41
 N/A 22 0 0 0 0 0
Cochran-Armitage test for telehealth utilization comparison between centers
AB AC AD BC BD CD
P value <.0001 <.0001 <.0001 <.0001 <.0001 0.039

Appt, Appointment type.

Cochran-Armitage test included to assess differences in telehealth-specific utilization between centers.

Table 2.

Total and center-specific utilization of telehealth visits by sex, appointment type, age group.

Variable Total (N = 15,240)
Center A
Center B
Center C
Center D
n % % % % %
Sex
 Female 8651 57 58 61 56 55
 Male 6580 43 42 38 44 45
 N/A 9 0 0 0 0 0
Appt
 FollowUp 9080 60 57 78 5 60
 NewPatient 1542 10 17 14 0 6
 Other 1532 10 0 0 92 13
 PostOp 3084 20 26 8 2 20
Age group
 50 or Less 1140 7 11 13 25 4
 50 to 70 8874 58 60 58 49 58
 70 and Above 5226 34 28 29 25 39

Appt, Appointment type.

Figure 1.

Figure 1

Overall and center-specific breakdown of telehealth usage by age over time.

Telehealth utilization over time

Before March 2020, nearly no telehealth visits occurred at any of the centers. The greatest utilization of telehealth visits occurred in April 2020 (center A 82%, center B 79%, center C 82%, center D 55%) across centers (Fig. 2). Utilization of telehealth visits from August 2020 to April 2021 stabilized around 2%-3% of total visits, yet there were significant differences in telehealth utilization trends across centers (Fig. 3; pairwise comparisons between centers, all P < .0001, except C-D, P = .039)

Figure 2.

Figure 2

Utilization of of in-person, telehealth, and telephone visits over time (January 1, 2020 – April 30, 2021) for the total cohort and by center.

Figure 3.

Figure 3

Month-over-month change in telehealth utilization for overall cohort and by center.

Demographics and telehealth utilization

There were no differences in telehealth utilization between male and female patients in total and across sites (Fig. 4; April 2020, P = .614; August 2020, P = .152; December 2020, P = .498; April 2021, P = .213). Patients younger than 50 years have had the highest utilization of telehealth visits since April 2020. This difference was noted at each center except for center D (Fig. 1).

Figure 4.

Figure 4

Overall and center-specific breakdown of telehealth usage by sex over time.

Appointment type and telehealth utilization

Across the cohort, from April 2020 to April 2021, telehealth utilization was greatest for follow-up and postoperative visits (Fig. 5). However, centers A, B, C, and D had statistical differences in telehealth utilization by appointment type, with greater utilization among follow-up and postoperative visits in all centers but one (Table 3; P < .0001).

Figure 5.

Figure 5

Overall and center-specific breakdown of telehealth usage by appointment type over time.

Table 3.

Center-specific breakdown of telehealth usage by appointment type over time (four time periods: 04/2020, 08/2020, 12/2020, 04/2021).

Center A 2020-04
2020-08
2020-12
2021-04
P value
% % % %
Appt <.0001
 FollowUp 37 67 60 77
 NewPatient 20 15 11 13
 Other 0 0 0 0
 PostOp
43
18
29
10
Center B





Appt <.0001
 FollowUp 83 72 67 70
 NewPatient 16 11 7 19
 Other 0 0 0 0
 PostOp
1
18
25
11
Center C





Appt <.0001
 FollowUp 7 0 10 0
 NewPatient 0 0 0 0
 Other 93 100 70 100
 PostOp
1
0
20
0
Center D





Appt <.0001
 FollowUp 65 36 32 47
 NewPatient 7 2 1 1
 Other 14 6 7 8
 PostOp 15 56 60 44

Appt, Appointment type.

Discussion

This multicenter study, which included four regionally diverse centers, analyzed hip and knee arthroplasty clinic telehealth utilization patterns starting from 2 months before the COVID-19 pandemic through 1 year after the start of the pandemic. There were several key findings in this study. First, despite an initial surge in telehealth utilization during the early pandemic, telehealth usage returned to minimal utilization among patients undergoing arthroplasty. Second, our data suggest that demographics may not influence telehealth utilization, except perhaps in younger patients. Finally, new patient evaluations are least likely to use telehealth, whereas postoperative and follow-up visits are most likely to occur over telehealth although practice variability exists in our cohort.

Although payment parity exists between telehealth and in-person visits, arthroplasty care has reverted to existing practice patterns of predominantly delivering care in-person. Our data indicate that, except for 2 months in the early pandemic, most patient clinic visits across centers have been in-person. This is a pattern that has emerged across orthopedic subspecialties. Through a statewide cohort study, Chao et al. [8] analyzed telehealth utilization across surgical subspecialties during the pandemic through September 2020. Their results found neurosurgery and urology to be the highest and orthopedic surgery to be either the lowest or second lowest in converting clinic appointments to telehealth. While the present study did not focus on identifying explanations for the return to low utilization of telehealth, this finding does not seem to be driven by low patient or surgeon satisfaction, as the orthopedic literature has identified high patient and surgeon satisfaction with telehealth [[9], [10], [11]]. Moreover, other fields in medicine, such as neurology [12], have incorporated telehealth into a significant portion of their practice, with certain clinics delivering over 25% of their care through telehealth. Despite low current usage of telehealth in orthopedic surgery, a systematic review by Jenkins et al [13] forecasts growth in utilization of telehealth as technological platforms and indications for telehealth usage mature.

Among arthroplasty patients, younger patients (<50 years of age) were more likely to use telehealth, while sex does not have an impact on telehealth utilization. The results of the present study are similar to those of Xiong et al. [14], who found that across two urban academic medical centers, telehealth users tended to be younger, whereas sex did not affect telehealth utilization. Their study was from March through May 2020; the present study adds to the literature by demonstrating these patterns persist through April 2021.

Of all arthroplasty clinic visits, new patient visits were least likely to take place over telehealth. In the present study, postoperative and follow-up visits were most likely to be performed over telehealth. It is possible that patients and surgeons feel these generally lower complexity visits are more appropriate to happen via telehealth, particularly during an ongoing pandemic. It is also possible that surgeons and/or patients feel an evaluation for surgical vs nonoperative care requires an in-person physical examination. However, other authors have shown that many orthopedic surgeons feel confident in diagnoses made over telehealth [10,15]. Furthermore, in a study by Crawford et al. [16], surgical plans delineated over telehealth were compared to final surgical plans after in-person visits. Across orthopedic surgery subspecialties, it was found these plans rarely change, and in arthroplasty, in particular, the plans did not change. These results should provide patients and surgeons the assurance that any type of arthroplasty visit can likely be performed effectively over telehealth in most patients.

There are several strengths to this study. First, it is multicenter, involving multiple regions and practice types, which allows for improved generalizability. Furthermore, it is the first arthroplasty study, to our knowledge, to analyze telehealth utilization over a 1-year period. There are limitations to this study, including reliance on accurate and consistent visit coding by each individual center. Furthermore, this study did not investigate reasons for intercenter or intracenter differences in telehealth utilization patterns over time. Moreover, another limitation is the retrospective nature of the study, making it subject to bias. Finally, this study did not differentiate patients based on diagnoses or treatment types, which may be a future study direction.

In conclusion, among arthroplasty clinics, telehealth utilization peaked during March and April of 2020, the height of the early pandemic, and has since reverted to near prepandemic clinical practice levels. Younger patients of either sex are more likely to use telehealth for arthroplasty appointments. Lower complexity visits such as postoperative visits or follow-up visits, as opposed to new patient evaluations, are more likely to use telehealth. We remain in the early phases of telehealth use in health care, and improvements in technology and regulation may make this mode of health-care delivery more commonplace in the future.

Conflicts of interest

M. Ast is in the editorial or governing board of Journal of Arthroplasty and is a committee member of AAHKS, AAOS, and EOA. J. D. Maratt is in the speakers’ bureau of or gave paid presentations for and is a paid consultant for Medacta; and is a board member of AAHKS Digital Health. C. A. Krueger is a paid consultant for Smit and Nephew and is a board member of AAOS and AAHKS. S. Bini received royalties from Stryker, has stock or stock options in InSilicoTrials.com, CaptureProof.com, Cloudmedix.com, and SiraMedical.com; received research support from Google.com, received financial or material support from Elsevier, is in the editorial or governing board of Journal of Arthroplasty and Arthroplasty Today; and is a board or committee member of American Association of Hip and Knee Surgeons and Personalized Arthroplasty Society.

Acknowledgments

The authors would like to thank Harry Manacsa for his assistance with data collection.

Supplementary data

Conflict of Interest Statement for Bendich
mmc1.pdf (74KB, pdf)
Conflict of Interest Statement for Chiu
mmc2.pdf (58.5KB, pdf)
Conflict of Interest Statement for Maratt
mmc3.docx (114.4KB, docx)
Conflict of Interest Statement for Ast
mmc4.docx (17.5KB, docx)
Conflict of Interest Statement for Krueger
mmc5.docx (191.5KB, docx)

Conflict of Interest Statement for Bini.

Conflict of Interest Statement for Bini

References

  • 1.Parisien R.L., Shin M., Constant M., et al. Telehealth utilization in response to the novel coronavirus (COVID-19) pandemic in orthopaedic surgery. J Am Acad Orthop Surg. 2020;28(11):e487. doi: 10.5435/JAAOS-D-20-00339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Makhni M.C., Riew G.J., Sumathipala M.G. Telemedicine in orthopaedic surgery: challenges and opportunities. JBJS. 2020;102(13):1109. doi: 10.2106/JBJS.20.00452. [DOI] [PubMed] [Google Scholar]
  • 3.Staff AJoMC . American Journal of Managed care. 2021. A Timeline of COVID-19 Developments in 2020.https://www.ajmc.com/view/a-timeline-of-covid19-developments-in-2020 [Google Scholar]
  • 4.Barnett M.L., Ray K.N., Souza J., Mehrotra A. Trends in telemedicine use in a large commercially insured population, 2005-2017. JAMA. 2018;320(20):2147. doi: 10.1001/jama.2018.12354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Windsor E.N., Sharma A.K., Gkiatas I., Elbuluk A.M., Sculco P.K., Vigdorchik J.M. An Overview of telehealth in total joint arthroplasty. HSS Journal. 2021;17(1):51. doi: 10.1177/1556331620972629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.LeBrun D.G., Malfer C., Wilson M., et al. Telemedicine in an outpatient Arthroplasty Setting during the COVID-19 pandemic: early Lessons from New York City. HSS Journal. 2021;17(1):25. doi: 10.1177/1556331620972659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Browne J.A. Leveraging early Discharge and telehealth technology to Safely Conserve Resources and minimize personal Contact during COVID-19 in an arthroplasty practice. J Arthroplasty. 2021;36(7S):S52. doi: 10.1016/j.arth.2021.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chao G.F., Li K.Y., Zhu Z., et al. Use of Telehealth by surgical specialties during the COVID-19 pandemic. JAMA Surg. 2021 doi: 10.1001/jamasurg.2021.0979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kirby D.J., Fried J.W., Buchalter D.B., et al. Patient and Physician satisfaction with telehealth during the COVID-19 pandemic: Sports medicine Perspective. Telemedicine and e-Health. 2021;27(10):1151. doi: 10.1089/tmj.2020.0387. [DOI] [PubMed] [Google Scholar]
  • 10.Chen J.S., Buchalter D.B., Sicat C.S., et al. Telemedicine during the COVID-19 pandemic: adult reconstructive surgery perspective. Bone Joint J. 2021;103(6 Supple A):196. doi: 10.1302/0301-620X.103B6.BJJ-2020-2097.R1. [DOI] [PubMed] [Google Scholar]
  • 11.Chaudhry H., Nadeem S., Mundi R. How satisfied are patients and surgeons with telemedicine in orthopaedic care during the COVID-19 pandemic? A systematic review and meta-analysis. Clin Orthopaedics Relat Research. 2021;479(1):47. doi: 10.1097/CORR.0000000000001494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Oliver B., Mehta F., Walsh K., England S. Telehealth utilization in MS centers during the COVID pandemic: Real-world evidence from the MS-CQI improvement research collaborative.(2368) AAN Enterprises. 2021 [Google Scholar]
  • 13.Jenkins J.M., Halai M., Synthesis C.O.R.R. What evidence is available for the Continued Use of telemedicine in orthopaedic surgery in the post-COVID-19 Era? Clin Orthopaedics Relat Research. 2021;479(4):747. doi: 10.1097/CORR.0000000000001444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Xiong G., Greene N.E., Lightsey I.V.H.M., et al. Telemedicine use in orthopaedic surgery varies by race, ethnicity, primary language, and insurance status. Clin Orthopaedics Relat Research. 2021;10:1097. doi: 10.1097/CORR.0000000000001775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bradley K.E., Cook C., Reinke E.K., et al. Comparison of the accuracy of telehealth examination versus clinical examination in the detection of shoulder pathology. J Shoulder Elbow Surg. 2021;30(5):1042. doi: 10.1016/j.jse.2020.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Crawford A.M., Lightsey H.M., Xiong G.X., Striano B.M., Schoenfeld A.J., Simpson A.K. Telemedicine visits generate accurate surgical plans across orthopaedic subspecialties. Arch Orthop Trauma Surg. 2021:1. doi: 10.1007/s00402-021-03903-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Conflict of Interest Statement for Bendich
mmc1.pdf (74KB, pdf)
Conflict of Interest Statement for Chiu
mmc2.pdf (58.5KB, pdf)
Conflict of Interest Statement for Maratt
mmc3.docx (114.4KB, docx)
Conflict of Interest Statement for Ast
mmc4.docx (17.5KB, docx)
Conflict of Interest Statement for Krueger
mmc5.docx (191.5KB, docx)

Articles from Arthroplasty Today are provided here courtesy of Elsevier

RESOURCES